Further to its intimations dated January 28, 2022 and February 01, 2022, Divi’s Laboratories has informed that the earnings conference call for Q3FY22 has been rescheduled to February 11, 2022. Details of the revised earnings conference call is enclosed.
The above information is a part of company’s filings submitted to BSE.